-
1
-
-
79956098248
-
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
-
Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 7:280-92. doi:10.1016/j.jalz.2011.03.003.
-
(2011)
Alzheimers Dement
, vol.7
, pp. 280-292
-
-
Sperling, R.A.1
Aisen, P.S.2
Beckett, L.A.3
Bennett, D.A.4
Craft, S.5
Fagan, A.M.6
-
2
-
-
84898447902
-
Plasma phospholipids identify antecedent memory impairment in older adults
-
Mapstone M, Cheema AK, Fiandaca MS, Zhong X, Mhyre TR, Macarthur LH, et al. Plasma phospholipids identify antecedent memory impairment in older adults. Nat Med (2014) 20:415-8. doi:10.1038/nm.3466.
-
(2014)
Nat Med
, vol.20
, pp. 415-418
-
-
Mapstone, M.1
Cheema, A.K.2
Fiandaca, M.S.3
Zhong, X.4
Mhyre, T.R.5
Macarthur, L.H.6
-
3
-
-
84902515726
-
The critical need for defining preclinical biomarkers in Alzheimer's disease
-
Fiandaca MS, Mapstone M, Cheema AK, FederoffHJ. The critical need for defining preclinical biomarkers in Alzheimer's disease. Alzheimers Dement (2014) 10:S195-211. doi:10.1016/j.jalz.2014.04.015.
-
(2014)
Alzheimers Dement
, vol.10
, pp. S195-S211
-
-
Fiandaca, M.S.1
Mapstone, M.2
Cheema, A.K.3
Federoff, H.J.4
-
4
-
-
0027457620
-
Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine
-
Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem (1993) 39:561-77.
-
(1993)
Clin Chem
, vol.39
, pp. 561-577
-
-
Zweig, M.H.1
Campbell, G.2
-
5
-
-
84887232805
-
Evidence of altered phosphatidylcholine metabolism in Alzheimer's disease
-
Whiley L, Sen A, Heaton J, Proitsi P, Garcia-Gomez D, Leung R, et al. Evidence of altered phosphatidylcholine metabolism in Alzheimer's disease. Neurobiol Aging (2014) 35:271-8. doi:10.1016/j.neurobiolaging.2013.08.001.
-
(2014)
Neurobiol Aging
, vol.35
, pp. 271-278
-
-
Whiley, L.1
Sen, A.2
Heaton, J.3
Proitsi, P.4
Garcia-Gomez, D.5
Leung, R.6
-
7
-
-
0001287271
-
Regression shrinkage and selection via the lasso
-
Tibshirani R. Regression shrinkage and selection via the lasso. J R Stat Soc B (1996) 58:267-88.
-
(1996)
J R Stat Soc B
, vol.58
, pp. 267-288
-
-
Tibshirani, R.1
-
8
-
-
0003684449
-
-
New York, NY: Springer-Verlag
-
Hastie T, Tibshirani R, Friedman J. The Elements of Statistical Learning; Data Mining, Inference, and Prediction. New York, NY: Springer-Verlag (2008).
-
(2008)
The Elements of Statistical Learning; Data Mining, Inference, and Prediction
-
-
Hastie, T.1
Tibshirani, R.2
Friedman, J.3
-
9
-
-
0037931319
-
Robustness against separation and outliers in logistic regression
-
Rousseeuw PJ, Christmann A. Robustness against separation and outliers in logistic regression. Comput Stat Data Anal (2003) 43:315-32. doi:10.1016/S0167-9473(02)00304-3.
-
(2003)
Comput Stat Data Anal
, vol.43
, pp. 315-332
-
-
Rousseeuw, P.J.1
Christmann, A.2
-
10
-
-
16244366026
-
Index for rating diagnostic tests
-
Youden WJ. Index for rating diagnostic tests. Cancer (1950) 3:32-5. doi:10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3.
-
(1950)
Cancer
, vol.3
, pp. 32-35
-
-
Youden, W.J.1
-
11
-
-
0026172948
-
Strategies for graphical threshold determination
-
Vermont J, Bosson JL, Francois P, Robert C, RueffA, Demongeot J. Strategies for graphical threshold determination. Comput Methods Programs Biomed (1991) 35:141-50. doi:10.1016/0169-2607(91)90072-2.
-
(1991)
Comput Methods Programs Biomed
, vol.35
, pp. 141-150
-
-
Vermont, J.1
Bosson, J.L.2
Francois, P.3
Robert, C.4
Rueff, A.5
Demongeot, J.6
-
12
-
-
36549073145
-
Prevalence of dementia in the United States: the aging, demographics, and memory study
-
Plassman BL, Langa KM, Fisher GG, Heeringa SG, Weir DR, Ofstedal MB, et al. Prevalence of dementia in the United States: the aging, demographics, and memory study. Neuroepidemiology (2007) 29:125-32. doi:10.1159/000109998.
-
(2007)
Neuroepidemiology
, vol.29
, pp. 125-132
-
-
Plassman, B.L.1
Langa, K.M.2
Fisher, G.G.3
Heeringa, S.G.4
Weir, D.R.5
Ofstedal, M.B.6
-
13
-
-
57749087174
-
Sample size for positive and negative predictive value in diagnostic research using case-control designs
-
Steinberg DM, Fine J, Chappell R. Sample size for positive and negative predictive value in diagnostic research using case-control designs. Biostatistics (2009) 10:94-105. doi:10.1093/biostatistics/kxn018.
-
(2009)
Biostatistics
, vol.10
, pp. 94-105
-
-
Steinberg, D.M.1
Fine, J.2
Chappell, R.3
-
14
-
-
84910005783
-
2014 Alzheimer's disease facts and figures
-
Alzheimer's A. 2014 Alzheimer's disease facts and figures. Alzheimers Dement (2014) 10:e47-92. doi:10.1016/j.jalz.2014.02.001.
-
(2014)
Alzheimers Dement
, vol.10
, pp. e47-e92
-
-
Alzheimer's, A.1
-
15
-
-
84949777459
-
Altered plasma phospholipid composition in autosomal dominant Alzheimer's disease: a DIAN study
-
Chatterjee P, Lim WLF, Gupta VB, Sorhabi HR, Taddei K, Brown B, et al. Altered plasma phospholipid composition in autosomal dominant Alzheimer's disease: a DIAN study. Alzheimers Dement (2014) 10:260. doi:10.1016/j.jalz.2014.04.412.
-
(2014)
Alzheimers Dement
, vol.10
, pp. 260
-
-
Chatterjee, P.1
Lim, W.L.F.2
Gupta, V.B.3
Sorhabi, H.R.4
Taddei, K.5
Brown, B.6
-
16
-
-
84919742683
-
Using direct infusion mass spectrometry for serum metabolomics in Alzheimer's disease
-
Gonzalez-Dominguez R, Garcia-Barrera T, Gomez-Ariza JL. Using direct infusion mass spectrometry for serum metabolomics in Alzheimer's disease. Anal Bioanal Chem (2014) 406:7137-48. doi:10.1007/s00216-014-8102-3.
-
(2014)
Anal Bioanal Chem
, vol.406
, pp. 7137-7148
-
-
Gonzalez-Dominguez, R.1
Garcia-Barrera, T.2
Gomez-Ariza, J.L.3
-
17
-
-
84927928846
-
Plasma lipidomics analysis finds long chain cholesteryl esters to be associated with Alzheimer's disease
-
Proitsi P, Kim M, Whiley L, Pritchard M, Leung R, Soininen H, et al. Plasma lipidomics analysis finds long chain cholesteryl esters to be associated with Alzheimer's disease. Transl Psychiatry (2015) 5:e494. doi:10.1038/tp.2014.127.
-
(2015)
Transl Psychiatry
, vol.5
-
-
Proitsi, P.1
Kim, M.2
Whiley, L.3
Pritchard, M.4
Leung, R.5
Soininen, H.6
-
18
-
-
84922398096
-
A nutritional approach to ameliorate altered phospholipid metabolism in Alzheimer's disease
-
Hartmann T, Van Wijk N, Wurtman RJ, Olde Rikkert MG, Sijben JW, Soininen H, et al. A nutritional approach to ameliorate altered phospholipid metabolism in Alzheimer's disease. J Alzheimers Dis (2014) 41:715-7. doi:10.3233/JAD-141137.
-
(2014)
J Alzheimers Dis
, vol.41
, pp. 715-717
-
-
Hartmann, T.1
Van Wijk, N.2
Wurtman, R.J.3
Olde Rikkert, M.G.4
Sijben, J.W.5
Soininen, H.6
-
19
-
-
77049118002
-
Lipid alterations in lipid rafts from Alzheimer's disease human brain cortex
-
Martin V, Fabelo N, Santpere G, Puig B, Marin R, Ferrer I, et al. Lipid alterations in lipid rafts from Alzheimer's disease human brain cortex. J Alzheimers Dis (2010) 19:489-502. doi:10.3233/JAD-2010-1242.
-
(2010)
J Alzheimers Dis
, vol.19
, pp. 489-502
-
-
Martin, V.1
Fabelo, N.2
Santpere, G.3
Puig, B.4
Marin, R.5
Ferrer, I.6
-
20
-
-
84910609998
-
GDNF signaling implemented by GM1 ganglioside; failure in Parkinson's disease and GM1-deficient murine model
-
Hadaczek P, Wu G, Sharma N, Ciesielska A, Bankiewicz K, Davidow AL, et al. GDNF signaling implemented by GM1 ganglioside; failure in Parkinson's disease and GM1-deficient murine model. Exp Neurol (2015) 263:177-89. doi:10.1016/j.expneurol.2014.10.010.
-
(2015)
Exp Neurol
, vol.263
, pp. 177-189
-
-
Hadaczek, P.1
Wu, G.2
Sharma, N.3
Ciesielska, A.4
Bankiewicz, K.5
Davidow, A.L.6
-
21
-
-
84856072382
-
Comparative lipidomic analysis of mouse and human brain with Alzheimer disease
-
Chan RB, Oliveira TG, Cortes EP, Honig LS, DuffKE, Small SA, et al. Comparative lipidomic analysis of mouse and human brain with Alzheimer disease. J Biol Chem (2012) 287:2678-88. doi:10.1074/jbc. M111.274142.
-
(2012)
J Biol Chem
, vol.287
, pp. 2678-2688
-
-
Chan, R.B.1
Oliveira, T.G.2
Cortes, E.P.3
Honig, L.S.4
Duff, K.E.5
Small, S.A.6
-
22
-
-
0026513962
-
Evidence for a membrane defect in Alzheimer disease brain
-
Nitsch RM, Blusztajn JK, Pittas AG, Slack BE, Growdon JH, Wurtman RJ. Evidence for a membrane defect in Alzheimer disease brain. Proc Natl Acad Sci U S A (1992) 89:1671-5. doi:10.1073/pnas.89.5.1671.
-
(1992)
Proc Natl Acad Sci U S A
, vol.89
, pp. 1671-1675
-
-
Nitsch, R.M.1
Blusztajn, J.K.2
Pittas, A.G.3
Slack, B.E.4
Growdon, J.H.5
Wurtman, R.J.6
-
23
-
-
0033791814
-
Membrane breakdown in acute and chronic neurodegeneration: focus on choline-containing phospholipids
-
Klein J. Membrane breakdown in acute and chronic neurodegeneration: focus on choline-containing phospholipids. J Neural Transm (2000) 107:1027-63. doi:10.1007/s007020070051.
-
(2000)
J Neural Transm
, vol.107
, pp. 1027-1063
-
-
Klein, J.1
-
24
-
-
80053334820
-
From brain to food: analysis of phosphatidylcholins, lyso-phosphatidylcholins and phosphatidylcholin-plasmalogens derivates in Alzheimer's disease human post mortem brains and mice model via mass spectrometry
-
Grimm MO, Grosgen S, Riemenschneider M, Tanila H, Grimm HS, Hartmann T. From brain to food: analysis of phosphatidylcholins, lyso-phosphatidylcholins and phosphatidylcholin-plasmalogens derivates in Alzheimer's disease human post mortem brains and mice model via mass spectrometry. J Chromatogr A (2011) 1218:7713-22. doi:10.1016/j.chroma.2011.07.073.
-
(2011)
J Chromatogr A
, vol.1218
, pp. 7713-7722
-
-
Grimm, M.O.1
Grosgen, S.2
Riemenschneider, M.3
Tanila, H.4
Grimm, H.S.5
Hartmann, T.6
-
25
-
-
84903640571
-
Metabolomic study of lipids in serum for biomarker discovery in Alzheimer's disease using direct infusion mass spectrometry
-
Gonzalez-Dominguez R, Garcia-Barrera T, Gomez-Ariza JL. Metabolomic study of lipids in serum for biomarker discovery in Alzheimer's disease using direct infusion mass spectrometry. J Pharm Biomed Anal (2014) 98:321-6. doi:10.1016/j.jpba.2014.05.023.
-
(2014)
J Pharm Biomed Anal
, vol.98
, pp. 321-326
-
-
Gonzalez-Dominguez, R.1
Garcia-Barrera, T.2
Gomez-Ariza, J.L.3
-
26
-
-
0034213298
-
Glycerophospholipids in brain: their metabolism, incorporation into membranes, functions, and involvement in neurological disorders
-
Farooqui AA, Horrocks LA, Farooqui T. Glycerophospholipids in brain: their metabolism, incorporation into membranes, functions, and involvement in neurological disorders. Chem Phys Lipids (2000) 106:1-29. doi:10.1016/S0009-3084(00)00128-6.
-
(2000)
Chem Phys Lipids
, vol.106
, pp. 1-29
-
-
Farooqui, A.A.1
Horrocks, L.A.2
Farooqui, T.3
-
27
-
-
0034500422
-
Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment
-
Conquer JA, Tierney MC, Zecevic J, Bettger WJ, Fisher RH. Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment. Lipids (2000) 35:1305-12. doi:10.1007/s11745-000-0646-3.
-
(2000)
Lipids
, vol.35
, pp. 1305-1312
-
-
Conquer, J.A.1
Tierney, M.C.2
Zecevic, J.3
Bettger, W.J.4
Fisher, R.H.5
-
28
-
-
0034912811
-
Essential polyunsaturated fatty acids and the barrier to the brain: the components of a model for transport
-
discussion 215-121
-
Edmond J. Essential polyunsaturated fatty acids and the barrier to the brain: the components of a model for transport. J Mol Neurosci (2001) 16:181-93; discussion 215-121.
-
(2001)
J Mol Neurosci
, vol.16
, pp. 181-193
-
-
Edmond, J.1
-
29
-
-
84922479473
-
Polyunsaturated fatty acids and their metabolites in brain function and disease
-
Bazinet RP, Laye S. Polyunsaturated fatty acids and their metabolites in brain function and disease. Nat Rev Neurosci (2014) 15:771-85. doi:10.1038/nrn3820.
-
(2014)
Nat Rev Neurosci
, vol.15
, pp. 771-785
-
-
Bazinet, R.P.1
Laye, S.2
-
30
-
-
0034912915
-
In vivo fatty acid incorporation into brain phosholipids in relation to plasma availability, signal transduction and membrane remodeling
-
discussion 279-284
-
Rapoport SI. In vivo fatty acid incorporation into brain phosholipids in relation to plasma availability, signal transduction and membrane remodeling. J Mol Neurosci (2001) 16:243-61; discussion 279-284.
-
(2001)
J Mol Neurosci
, vol.16
, pp. 243-261
-
-
Rapoport, S.I.1
-
31
-
-
0018385493
-
Lipoprotein lipase and acid lipase activity in rabbit brain microvessels
-
Brecher P, Kuan HT. Lipoprotein lipase and acid lipase activity in rabbit brain microvessels. J Lipid Res (1979) 20:464-71.
-
(1979)
J Lipid Res
, vol.20
, pp. 464-471
-
-
Brecher, P.1
Kuan, H.T.2
-
32
-
-
0030972045
-
No evidence for direct incorporation of esterified palmitic acid from plasma into brain lipids of awake adult rat
-
Purdon D, Arai T, Rapoport S. No evidence for direct incorporation of esterified palmitic acid from plasma into brain lipids of awake adult rat. J Lipid Res (1997) 38:526-30.
-
(1997)
J Lipid Res
, vol.38
, pp. 526-530
-
-
Purdon, D.1
Arai, T.2
Rapoport, S.3
-
33
-
-
0034913114
-
Plasma free fatty acid and lipoproteins as sources of polyunsaturated fatty acid for the brain
-
discussion 215-121
-
Spector AA. Plasma free fatty acid and lipoproteins as sources of polyunsaturated fatty acid for the brain. J Mol Neurosci (2001) 16:159-65; discussion 215-121.
-
(2001)
J Mol Neurosci
, vol.16
, pp. 159-165
-
-
Spector, A.A.1
-
34
-
-
0028898743
-
Coenzyme A-dependent cleavage of membrane phospholipids in several rat tissues: ATP-independent acyl-CoA synthesis and the generation of lysophospholipids
-
Sugiura T, Kudo N, Ojima T, Mabuchi-Itoh K, Yamashita A, Waku K. Coenzyme A-dependent cleavage of membrane phospholipids in several rat tissues: ATP-independent acyl-CoA synthesis and the generation of lysophospholipids. Biochim Biophys Acta (1995) 1255:167-76. doi:10.1016/0005-2760(94)00237-S.
-
(1995)
Biochim Biophys Acta
, vol.1255
, pp. 167-176
-
-
Sugiura, T.1
Kudo, N.2
Ojima, T.3
Mabuchi-Itoh, K.4
Yamashita, A.5
Waku, K.6
-
35
-
-
0030809527
-
Relation between free fatty acid and acyl-CoA concentrations in rat brain following decapitation
-
Deutsch J, Rapoport SI, Purdon AD. Relation between free fatty acid and acyl-CoA concentrations in rat brain following decapitation. Neurochem Res (1997) 22:759-65. doi:10.1023/A:1022030306359.
-
(1997)
Neurochem Res
, vol.22
, pp. 759-765
-
-
Deutsch, J.1
Rapoport, S.I.2
Purdon, A.D.3
-
36
-
-
0030946557
-
Changes in cerebral acyl-CoA concentrations following ischemia-reperfusion in awake gerbils
-
Rabin O, Deutsch J, Grange E, Pettigrew KD, Chang MC, Rapoport SI, et al. Changes in cerebral acyl-CoA concentrations following ischemia-reperfusion in awake gerbils. J Neurochem (1997) 68:2111-8. doi:10.1046/j.1471-4159.1997.68052111.x.
-
(1997)
J Neurochem
, vol.68
, pp. 2111-2118
-
-
Rabin, O.1
Deutsch, J.2
Grange, E.3
Pettigrew, K.D.4
Chang, M.C.5
Rapoport, S.I.6
-
37
-
-
0034988945
-
Delivery and turnover of plasma-derived essential PUFAs in mammalian brain
-
Rapoport SI, Chang MCJ, Spector AA. Delivery and turnover of plasma-derived essential PUFAs in mammalian brain. J Lipid Res (2001) 42:678-85.
-
(2001)
J Lipid Res
, vol.42
, pp. 678-685
-
-
Rapoport, S.I.1
Chang, M.C.J.2
Spector, A.A.3
-
38
-
-
0000749205
-
The function of cytidine coenzymes in the biosynthesis of phospholipides
-
Kennedy EP, Weiss SB. The function of cytidine coenzymes in the biosynthesis of phospholipides. J Biol Chem (1956) 222:193-214.
-
(1956)
J Biol Chem
, vol.222
, pp. 193-214
-
-
Kennedy, E.P.1
Weiss, S.B.2
-
39
-
-
84889770932
-
Targeting synaptic dysfunction in Alzheimer's disease by administering a specific nutrient combination
-
van Wijk N, Broersen LM, De Wilde MC, Hageman RJ, Groenendijk M, Sijben JW, et al. Targeting synaptic dysfunction in Alzheimer's disease by administering a specific nutrient combination. J Alzheimers Dis (2014) 38:459-79. doi:10.3233/JAD-130998.
-
(2014)
J Alzheimers Dis
, vol.38
, pp. 459-479
-
-
van Wijk, N.1
Broersen, L.M.2
De Wilde, M.C.3
Hageman, R.J.4
Groenendijk, M.5
Sijben, J.W.6
-
40
-
-
84900312887
-
The effect of souvenaid on functional brain network organisation in patients with mild Alzheimer's disease: a randomised controlled study
-
de Waal H, Stam CJ, Lansbergen MM, Wieggers RL, Kamphuis PJ, Scheltens P, et al. The effect of souvenaid on functional brain network organisation in patients with mild Alzheimer's disease: a randomised controlled study. PLoS One (2014) 9:e86558. doi:10.1371/journal.pone.0086558.
-
(2014)
PLoS One
, vol.9
-
-
de Waal, H.1
Stam, C.J.2
Lansbergen, M.M.3
Wieggers, R.L.4
Kamphuis, P.J.5
Scheltens, P.6
-
41
-
-
84942509989
-
Antiphospholipid autoantibodies as blood biomarkers for detection of early stage Alzheimer's disease
-
McIntyre JA, Ramsey CJ, Gitter BD, Saykin AJ, Wagenknecht DR, Hyslop PA, et al. Antiphospholipid autoantibodies as blood biomarkers for detection of early stage Alzheimer's disease. Autoimmunity (2015) 48(5):344-51. doi:10.3109/08916934.2015.1008464.
-
(2015)
Autoimmunity
, vol.48
, Issue.5
, pp. 344-351
-
-
McIntyre, J.A.1
Ramsey, C.J.2
Gitter, B.D.3
Saykin, A.J.4
Wagenknecht, D.R.5
Hyslop, P.A.6
-
43
-
-
7144257853
-
Neurotransmitter amino acids in cerebrospinal fluid of patients with Alzheimer's disease
-
Jimenez-Jimenez FJ, Molina JA, Gomez P, Vargas C, De Bustos F, Benito-Leon J, et al. Neurotransmitter amino acids in cerebrospinal fluid of patients with Alzheimer's disease. J Neural Transm (1998) 105:269-77. doi:10.1007/s007020050073.
-
(1998)
J Neural Transm
, vol.105
, pp. 269-277
-
-
Jimenez-Jimenez, F.J.1
Molina, J.A.2
Gomez, P.3
Vargas, C.4
De Bustos, F.5
Benito-Leon, J.6
-
44
-
-
0016209777
-
Psychiatric symptoms associated with L-asparaginase administration
-
Holland J, Fasanello S, Onuma T. Psychiatric symptoms associated with L-asparaginase administration. J Psychiatr Res (1974) 10:105-13. doi:10.1016/0022-3956(74)90030-2.
-
(1974)
J Psychiatr Res
, vol.10
, pp. 105-113
-
-
Holland, J.1
Fasanello, S.2
Onuma, T.3
-
45
-
-
0015008112
-
Studies on the utilization of asparagine by mouse leukemia cells
-
Ubuka T, Meister A. Studies on the utilization of asparagine by mouse leukemia cells. J Natl Cancer Inst (1971) 46:291-8.
-
(1971)
J Natl Cancer Inst
, vol.46
, pp. 291-298
-
-
Ubuka, T.1
Meister, A.2
-
46
-
-
0019377631
-
Synthesis and processing of asparagine-linked oligosaccharides
-
Hubbard SC, Ivatt RJ. Synthesis and processing of asparagine-linked oligosaccharides. Annu Rev Biochem (1981) 50:555-83. doi:10.1146/annurev.bi.50.070181.003011.
-
(1981)
Annu Rev Biochem
, vol.50
, pp. 555-583
-
-
Hubbard, S.C.1
Ivatt, R.J.2
-
47
-
-
84885758467
-
Deficiency of asparagine synthetase causes congenital microcephaly and a progressive form of encephalopathy
-
Ruzzo EK, Capo-Chichi JM, Ben-Zeev B, Chitayat D, Mao H, Pappas AL, et al. Deficiency of asparagine synthetase causes congenital microcephaly and a progressive form of encephalopathy. Neuron (2013) 80:429-41. doi:10.1016/j.neuron.2013.08.013.
-
(2013)
Neuron
, vol.80
, pp. 429-441
-
-
Ruzzo, E.K.1
Capo-Chichi, J.M.2
Ben-Zeev, B.3
Chitayat, D.4
Mao, H.5
Pappas, A.L.6
-
48
-
-
79953296231
-
The therapeutic potential of targeting endogenous inhibitors of nitric oxide synthesis
-
Leiper J, Nandi M. The therapeutic potential of targeting endogenous inhibitors of nitric oxide synthesis. Nat Rev Drug Discov (2011) 10:277-91. doi:10.1038/nrd3358.
-
(2011)
Nat Rev Drug Discov
, vol.10
, pp. 277-291
-
-
Leiper, J.1
Nandi, M.2
-
49
-
-
65249119330
-
Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community
-
Boger RH, Sullivan LM, Schwedhelm E, Wang TJ, Maas R, Benjamin EJ, et al. Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community. Circulation (2009) 119:1592-600. doi:10.1161/CIRCULATIONAHA.108.838268.
-
(2009)
Circulation
, vol.119
, pp. 1592-1600
-
-
Boger, R.H.1
Sullivan, L.M.2
Schwedhelm, E.3
Wang, T.J.4
Maas, R.5
Benjamin, E.J.6
-
50
-
-
0035425503
-
Nitric oxide synthases: structure, function and inhibition
-
Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: structure, function and inhibition. Biochem J (2001) 357:593-615. doi:10.1042/0264-6021:3570593.
-
(2001)
Biochem J
, vol.357
, pp. 593-615
-
-
Alderton, W.K.1
Cooper, C.E.2
Knowles, R.G.3
-
51
-
-
39349090970
-
NO/cGMP-dependent modulation of synaptic transmission
-
Feil R, Kleppisch T. NO/cGMP-dependent modulation of synaptic transmission. Handb Exp Pharmacol (2008) 184:529-60. doi:10.1007/978-3-540-74805-2_16.
-
(2008)
Handb Exp Pharmacol
, vol.184
, pp. 529-560
-
-
Feil, R.1
Kleppisch, T.2
-
52
-
-
47949116906
-
Asymmetrical dimethylarginine is increased in plasma and decreased in cerebrospinal fluid of patients with Alzheimer's disease
-
Arlt S, Schulze F, Eichenlaub M, Maas R, Lehmbeck JT, Schwedhelm E, et al. Asymmetrical dimethylarginine is increased in plasma and decreased in cerebrospinal fluid of patients with Alzheimer's disease. Dement Geriatr Cogn Disord (2008) 26:58-64. doi:10.1159/000144026.
-
(2008)
Dement Geriatr Cogn Disord
, vol.26
, pp. 58-64
-
-
Arlt, S.1
Schulze, F.2
Eichenlaub, M.3
Maas, R.4
Lehmbeck, J.T.5
Schwedhelm, E.6
-
53
-
-
84928114518
-
The cerebral circulation: function and dysfunction in Alzheimer's disease
-
Hamel E. The cerebral circulation: function and dysfunction in Alzheimer's disease. J Cardiovasc Pharmacol (2014) 65:317-24. doi:10.1097/FJC.0000000000000177.
-
(2014)
J Cardiovasc Pharmacol
, vol.65
, pp. 317-324
-
-
Hamel, E.1
-
54
-
-
0032469313
-
Taking a count: the evaluation of genetic testing
-
Hall J, Viney R, Haas M. Taking a count: the evaluation of genetic testing. Aust N Z J Public Health (1998) 22:754-8. doi:10.1111/j.1467-842X.1998.tb01488.x.
-
(1998)
Aust N Z J Public Health
, vol.22
, pp. 754-758
-
-
Hall, J.1
Viney, R.2
Haas, M.3
-
55
-
-
1442276551
-
The hazards of early recognition of dementia: a risk assessment
-
Lliffe S, Manthorpe J. The hazards of early recognition of dementia: a risk assessment. Aging Ment Health (2004) 8:99-105. doi:10.1080/13607860410001649653.
-
(2004)
Aging Ment Health
, vol.8
, pp. 99-105
-
-
Lliffe, S.1
Manthorpe, J.2
-
56
-
-
0026609094
-
Discrimination as a consequence of genetic testing
-
Billings PR, Kohn MA, De Cuevas M, Beckwith J, Alper JS, Natowicz MR. Discrimination as a consequence of genetic testing. Am J Hum Genet (1992) 50:476-82.
-
(1992)
Am J Hum Genet
, vol.50
, pp. 476-482
-
-
Billings, P.R.1
Kohn, M.A.2
De Cuevas, M.3
Beckwith, J.4
Alper, J.S.5
Natowicz, M.R.6
-
57
-
-
58249093641
-
Economic methods for valuing the outcomes of genetic testing: beyond cost-effectiveness analysis
-
Grosse SD, Wordsworth S, Payne K. Economic methods for valuing the outcomes of genetic testing: beyond cost-effectiveness analysis. Genet Med (2008) 10:648-54. doi:10.1097/GIM.0b013e3181837217.
-
(2008)
Genet Med
, vol.10
, pp. 648-654
-
-
Grosse, S.D.1
Wordsworth, S.2
Payne, K.3
-
58
-
-
84965172390
-
Dementia risk and financial decision making by older households: the impact of information
-
Hsu JW, Willis R. Dementia risk and financial decision making by older households: the impact of information. J Hum Cap (2013) 2013:45. doi:10.2139/ssrn.2339225.
-
(2013)
J Hum Cap
, vol.2013
, pp. 45
-
-
Hsu, J.W.1
Willis, R.2
-
59
-
-
0034086974
-
Assessing financial capacity in patients with Alzheimer disease: a conceptual model and prototype instrument
-
Marson DC, Sawrie SM, Snyder S, McinturffB, Stalvey T, Boothe A, et al. Assessing financial capacity in patients with Alzheimer disease: a conceptual model and prototype instrument. Arch Neurol (2000) 57:877-84. doi:10.1001/archneur.57.6.877.
-
(2000)
Arch Neurol
, vol.57
, pp. 877-884
-
-
Marson, D.C.1
Sawrie, S.M.2
Snyder, S.3
Mcinturff, B.4
Stalvey, T.5
Boothe, A.6
-
60
-
-
44649111224
-
Declining financial capacity in patients with mild Alzheimer disease: a one-year longitudinal study
-
Martin R, Griffith HR, Belue K, Harrell L, Zamrini E, Anderson B, et al. Declining financial capacity in patients with mild Alzheimer disease: a one-year longitudinal study. Am J Geriatr Psychiatry (2008) 16:209-19. doi:10.1097/JGP.0b013e318157cb00.
-
(2008)
Am J Geriatr Psychiatry
, vol.16
, pp. 209-219
-
-
Martin, R.1
Griffith, H.R.2
Belue, K.3
Harrell, L.4
Zamrini, E.5
Anderson, B.6
-
61
-
-
70349655698
-
Declining financial capacity in mild cognitive impairment: a 1-year longitudinal study
-
Triebel KL, Martin R, Griffith HR, Marceaux J, Okonkwo OC, Harrell L, et al. Declining financial capacity in mild cognitive impairment: a 1-year longitudinal study. Neurology (2009) 73:928-34. doi:10.1212/WNL.0b013e3181b87971.
-
(2009)
Neurology
, vol.73
, pp. 928-934
-
-
Triebel, K.L.1
Martin, R.2
Griffith, H.R.3
Marceaux, J.4
Okonkwo, O.C.5
Harrell, L.6
-
62
-
-
84898042637
-
How are we going to live with Alzheimer's disease?
-
Karlawish J. How are we going to live with Alzheimer's disease? Health Aff(Millwood) (2014) 33:541-6. doi:10.1377/hlthaff.2014.0089.
-
(2014)
Health Aff(Millwood)
, vol.33
, pp. 541-546
-
-
Karlawish, J.1
-
63
-
-
84898038424
-
Alzheimer's disease legislation and policy-now and in the future
-
Hoffman D. Alzheimer's disease legislation and policy-now and in the future. Health Aff(Millwood) (2014) 33:561-5. doi:10.1377/hlthaff.2013.1223.
-
(2014)
Health Aff(Millwood)
, vol.33
, pp. 561-565
-
-
Hoffman, D.1
-
64
-
-
84949917720
-
Presidential Commission for the Study of Bioethical Issues Report
-
Ethics, and Society, Washington, DC: US Dept Health and Human Services
-
Guttman A, Wagner JW, Allen AL, Arras JD, Atkinson BF, Farahany NA, et al. Presidential Commission for the Study of Bioethical Issues Report, GRAY MATTERS-Integrative Approaches for Neuroscience, Ethics, and Society. Washington, DC: US Dept Health and Human Services (2014). http://www.bioethics.gov/sites/default/files/Gray%20Matters%20Vol%201.pdf.
-
(2014)
GRAY MATTERS-Integrative Approaches for Neuroscience
-
-
Guttman, A.1
Wagner, J.W.2
Allen, A.L.3
Arras, J.D.4
Atkinson, B.F.5
Farahany, N.A.6
-
65
-
-
79959193198
-
Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors
-
Goldman JS, Hahn SE, Catania JW, Larusse-Eckert S, Butson MB, Rumbaugh M, et al. Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors. Genet Med (2011) 13:597-605. doi:10.1097/GIM.0b013e31821d69b8.
-
(2011)
Genet Med
, vol.13
, pp. 597-605
-
-
Goldman, J.S.1
Hahn, S.E.2
Catania, J.W.3
Larusse-Eckert, S.4
Butson, M.B.5
Rumbaugh, M.6
|